Viewing StudyNCT03654716



Ignite Creation Date: 2024-05-06 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 12:53 PM
Study NCT ID: NCT03654716
Status: COMPLETED
Last Update Posted: 2023-08-14
First Post: 2018-08-29

Brief Title: Phase 1 Study of the Dual MDM2MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Leukemia
Brain Tumor
Solid Tumor
Keywords:
Name View
PPM1D View
Leukemia View
Solid Tumor View
Brain Tumor View
Lymphoma View
TP53 View
p53 View
MDM2 View
MDMX View